MiR181-5p promotes pathogenic angiogenesis of hepatopulmonary syndrome by negatively regulating Wnt inhibitor WIF1

Document Type : Original Article


1 Department of Anesthesiology, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China

2 College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, 400016, China


Objective(s): Hepatopulmonary syndrome is a serious respiratory injury caused by chronic liver disease. Excessive pulmonary capillary angiogenesis is the key pathological event. However, the mechanism of microRNA regulatory pulmonary capillary angiogenesis is still unclear.
Materials and Methods: The hepatopulmonary syndrome rat model was constructed by Common bile duct ligation (CBDL) surgery. The expression tread of miR181-5p and Wif1 was detected by qRT-PCR and western blot in various tissues and disease processes. Wif1 was predicted as one of the potential target genes of miR181-5p by bioinformatic assay. miR181-5p mimics and inhibitors were used to increase/decrease miR181-5p levels in pulmonary microvascular cells. And Wif-1 specific recombinant lentiviruses were used to up-regulate and down-regulate Wif1 in pulmonary microvascular cells. Then, CCK8, Transwell, and tube formation assay were used for pulmonary microvascular cell proliferation, migration, and tube formation. And Dual-luciferase reporter assay was used to assess that miR181-5p may direct regulate Wif-1 in HPS rats. 
Results: The result showed miR181-5p specifically activates the Wnt signaling pathway by inhibiting Wif1 and then promotes pulmonary microvascular cell proliferation, migration, and tube formation, thereby accelerating the process of HPS. We finally verified Wif1 as a novel and direct target of miR181-5p in HPS. 
Conclusion: Taken together, we revealed an important miR-181-5p/Wif1/Wnt pathway in regulating pathological angiogenesis. It will prove beneficial as a therapeutic strategy for hepatopulmonary syndrome.


Main Subjects

1. Villa E, Fattovich G, Mauro A, Pasino M. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Dig Liver Dis 2011; 43:8-14.
2.    Wang D, Fu B, Shen X, Guo C, Liu Y, Zhang J, et al. Tian, restoration of HBV-specific CD8+T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy. Signal Transduct Target Ther 2021; 6:376-389.
3.    Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 2000; 32:859-865.
4.    Katsuta Y, Zhang XJ, Ohsuga M, Akimoto T, Komeichi H, Shimizu S, et al. Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension. J Gastroenterol 2005; 40:811-819.
5.    Bartel DP. MicroRNA target recognition and regulatory functions. Cell 2009; 136:215-233.
6.    Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Gen 2008; 9:102-114.
7.    Ivey KN, Srivastava D. MicroRNAs as developmental regulators. Cold Spring Harb 2015; 7: a008144.
8.    Alessio D, Francesco M, Li JH, Alessandra M, Kyriakides TR. Angiogenesis and vasculogenesis in health and disease. Biomed Res Int 2015; 2015:1-2.
9.    Negrao R, Costa R, Duarte D, Gomes TT, Mendanha M, Moura L, et al. Angiogenesis and inflammation signaling are targets of beer polyphenols on vascular cells. J Cell Biochem 2010; 111:1270-1279.
10.    Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438:932-936.
11.    Congwen Y, Keyi L, Chen B, Yang y, Ai X, Hongfu Y, et al. MiR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2. Exp Cell Res 2018; 365:291-291.
12.    Zeng J, Chen L, Chen B, Lu K, Belguise K, Wang X, et al. MicroRNA-199a-5p regulates the proliferation of pulmonary microvascular endothelial cells in hepatopulmonary syndrome. Cell Physiol Biochem 2015; 37:1289-1300.
13.    Xu D, Gu GT, Yi B, Chen L, Wang GS, Qian GS, et al. Requirement of miR-9-dependent regulation of myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum. J Cell Mol Med 2015; 19:2453-2461.
14.    Chen L, Li YS, Cui J, Ning JN, Wang GS, Qian GS, et al. MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2. Cell Physiol Biochem 2014; 34:1768-1779.
15.    Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, et al. A new secreted protein that binds to Wnt proteins and inhibits their activites. Nature 1999; 398:431-436.
16.    Nestor T, Masckauchan H, Kitajewski J. Wnt/frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology 2006; 21:181-188.
17.    Easwaran V, Sang HL, Inge L, Guo L, Fantl WJ. Beta-catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003, 63:3145-3153.
18.    Wright M, Aikawa M, Szeto W, Papkoff J. Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun 1999; 263:384-388.
19.    Yang Y, Chen B, Chen Y, Zu B, Yi B, Lu K. A comparison of two common bile duct ligation methods to establish hepatopulmonary syndrome animal models. Lab Anim 2014; 49:71-79.
20.    Yang C, Lin Y, Liu H, Shen G, Xia Q. The broad complex isoform 2 (BrC-Z2) transcriptional factor plays a critical role in vitellogenin transcription in the silkworm bombyx mori. Biochim Biophys Acta Gen Subj 2014; 1840:2674-2684.
21.    Cui J, Zhao H, Yi B, Zeng J, Lu K, Ma D. Dexmedetomidine attenuates bilirubin-induced lung alveolar epithelial cell death in vitro and in vivo. Crit Care Med 2015; 43:356-368.
22.    Yi B, Jing Z, Wang G, Qian G. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling. J Transl Med 2013; 11:1-8.
23.    Rezabakhsh A, Nabat E, Yousefi M, Montazersaheb S, Cheraghi O, Mehdizadeh A, et al. Endothelial cells’ biophysical, biochemical, and chromosomal aberrancies in high‐glucose condition within the diabetic range. Cell Biochem Funct 2017; 35:83-97.
24.    Mannell H, Kameritsch P, Beck H, Pfeifer A, Pohl U, Pogoda K. Cx43 promotes endothelial cell migration and angiogenesis via the tyrosine phosphatase SHP-2. Int J Mol Sci 2021; 23:294-307.
25.    DeCicco-Skinner KL, Henry GH, Cataisson C, Tabib T, Gwilliam JC, Watson NJ, et al. Endothelial cell tube formation assay for the in vitro study of angiogenesis. J Vis Exp 2014; 91:e51312.
26.    Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012; 31;2725-2737.
27.    Zhang B, Ma JX. Wnt pathway antagonists and angiogenesis. Protein Cell 2010; 1:898-906.
28.    Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781-810.
29.    Shu W, Jiang YQ, Lu MM, Morrisey EE. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002; 129:4831-4842.
30.    Yang C, Lv K, Chen b, Yang Y, Ai X, Yu H, et al. MiR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2. Exp cell Res 2018; 1:24-32.
31.    Zhang W, Zhu T, Wu W, Ge X, Xiong X, Zhang Z, et al. LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension. Eur J Pharmacol 2017; 818:84-95.
32.    Yang C, Wen X, Zhi W, Jing Z, Chen B, Yong Y, et al. Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin, Biochem Biophys Res Commun 2016; 469:70-75.
33.    Chen Y, Yang C, Li Y, Chen L, Yi B. MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia. Biol Open 2019; 8:11-21.
34.    Grewers Z, Krueger A. MicroRNA miR-181-A rheostat for TCR signaling in thymic selection and peripheral T-cell function. Int J Mol Sci 2020; 21:17-32.
35.    Maryam M, Naemi M, Hasani SS. A comprehensive review on oncogenic miRNAs in breast cancer. J Genet 2021; 15:100-.
36.    Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B. The pervasive role of the miR-181 family in development, neurodegeneration, and cancer, Int J Mol Sci 2020; 21:16-41.
37.    Rezaei T, Amini M, Hashemi ZS, Mansoori B, Rezaei S, Karami H, et al. MicroRNA-181 serves as a dual-role regulator in the development of human cancers. Free Rad Biol Med 2020; 152:432-454.
38.    Yang C, Passos Gibson V, Hardy P. The role of mir-181 family members in endothelial cell dysfunction and tumor angiogenesis. Cells 2022; 11:1670-1688.
39.    Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31:99-109. 
40.    Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R. The drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987; 50:649-657.
41.    Huang P, R Yan, Zhang X, Wang L, Ke X, Qu Y. Activating Wnt/β-catenin signaling pathway for disease therapy: challenges and opportunities. Pharmacol Ther 2019; 196:79-90.
42.    Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hepatol Oncol 2020; 13:165-183.